Latest News

DOJ won’t defend ACA from lawsuit challenging constitutionality


 


However, the DOJ does not agree that the balance of the law outside of the individual mandate and the inseverable guaranteed issue and community rating provisions should remain in tact.

The court filing argues that the request for a temporary injunction to declare the individual mandate unconstitutional should not be allowed because the individual mandate’s penalty for non-coverage is in effect through 2018, therefore it remains constitutional.


“That said, because this is a pure question of law on which the Plaintiffs and Defendants do not disagree, the Court should consider construing Plaintiff’s motion as a request for summary judgment and then entering a declaratory judgment that the ACA’s provisions establishing the individual mandate as well as the guaranteed-issue and community-rating requirements will all be invalid as of January 1, 2019. That would be adequate relief against the government.”

Former CMS Administrator Andy Slavitt in a tweet called the government’s desire to push any decision until the new year, which would come after the midterm elections, an act of “savage cynicism.” He added in a later tweet that “people who care about public health don’t do this. People who care about the rule of law don’t do this.”

Recommended Reading

MDedge Daily News: Keeping patients summer safe
MDedge Dermatology
Peer mentorship, groups help combat burnout in female physicians
MDedge Dermatology
Effects of psoriatic arthritis not just physical
MDedge Dermatology
Practice management pearls: Advice from seasoned doctors for residents looking to start a practice
MDedge Dermatology
Cryolipolysis leads surge in body sculpting
MDedge Dermatology
Looking for lower Medicare drug costs? Ask your pharmacist for the cash price
MDedge Dermatology
Verma unveils Medicaid scorecard but refuses to judge efforts
MDedge Dermatology
Modifier -25 Victory, But the Battle Is Not Over
MDedge Dermatology
HHS to allow insurers’ workaround on 2019 prices
MDedge Dermatology
FDA effort focuses on approving more generic drugs
MDedge Dermatology